AUG 15, 2018 12:27 AM PDT

Peripheral Nerve Blockers Treat Facial Pain

WRITTEN BY: Nouran Amin

A new research study published in the American Journal of Emergency Medicine explains the use of peripheral nerve inhibitors in the treatment of facial pain condition known as Trigeminal Neuralgia (TGN). TGN involves sudden episodes of severe facial pain that can significantly reduce the quality of life for affected individuals.

Some patients seek highly precise invasive procedures when proper medication fails to manage the pain. However, invasive procedures often leave patients with discomfort and the long period of numbness. Fortunately, the study examined alternatives that can give patients promising results with less discomfort. Such an alternative is Peripheral Trigeminal Nerve Blocks (PTNB). PTNB can be thought of as another procedure in which a numbing medication is administered through an injection at the site where the problem nerve reaches the facial pain area. Although PTNB serves as a promising alternative, the efficacy of this particular drug has not been well studied in both short-term and long-term management of TGN.

Image Retrieved From Unsplash, www.unsplash.com

During a case series in the American Journal of Emergency Medicine, Michael Perloff, MD, a clinical neurologist and an assistant professor of neurology at Boston University School of Medicine, examined nine TGN patients that were treated with PTNB. Perloff found that all nine patients had an immediate relief of their pain after the administered procedure, with many reporting pain-free feeling. Additionally, six of these nine patients reported continued pain relief from a range of one to eight months that followed the procedure, with two of the patients experiencing a complete resolution of their pain months after the administered injections. Perloff believes these results to be an encouraging step towards effective pain management for patients with TGN. "PTNB can be a simple, safe alternative compared to opioids, invasive ganglion level procedures or surgery."

Source: Boston University School of Medicine

About the Author
  • Nouran enjoys writing on various topics including science & medicine, global health, and conservation biology. She hopes through her writing she can make science more engaging and communicable to the general public.
You May Also Like
JUN 13, 2018
Drug Discovery
JUN 13, 2018
Virtual Reality and Drug Discovery
A drug discovery company known as C4X Discovery (C4XD) has developed its very own virtual reality (VR) tool known as 4Sight, which helps chemist visualize...
JUN 27, 2018
Drug Discovery
JUN 27, 2018
Potential Drug May 'Freeze' Cancer Cells
New research study is bringing hope to cancer patients undergoing the early stages of the disease, published in the journal Nature Communications, the stud...
JUL 17, 2018
Videos
JUL 17, 2018
Novartis Ends Antibiotic Research
The United Nations has warned that by 2050, antibiotic-resistant microbes might kill ten million people every year....
AUG 25, 2018
Videos
AUG 25, 2018
Engineering Targeted Nanoparticles
The Koch Institute at MIT has chosen one of Jason Chang's images as an Image Award recipient for 2018....
SEP 11, 2018
Drug Discovery
SEP 11, 2018
Widely-Used Drug Contributed To Skin Cancer
In a research study at the University of Dundee, Queen Mary University of London and the Wellcome Sanger Institute, a drug, by the name of azathioprine, wh...
SEP 18, 2018
Drug Discovery
SEP 18, 2018
Clinical-Grade Drugs for Bone Diseases
According to a study published in Journal of Gerontology: Biological Sciences, a small molecule was discovered to play a role in bone formation, ultimately...
Loading Comments...